Georgetown University - Lombardi Comprehensive Cancer Center

3970 Reservoir Road Northwest
Washington, D.C., District of Columbia 20007

We've found

1 trials

at this facility

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Status: Enrolling, Phase I, II
Updated: 7/25/2017

from

Washington DC,

Use our guide to learn which trials are right for you!